Serum metabolomics identifies ganglioside dysregulation and pyruvate dehydrogenase complex-related metabolic disturbances in pediatric drug-resistant epilepsy.

Abu-Rish EY, AlMalki RH, Masri A, Dahabiyeh LA, Alnajjar R, Darwish RM, Abdel Rahman AM.

Open source

DOI
10.3389/fped.2026.1952153
Published
2026-09-29
Container
Front Pediatr
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2026.1952153,
  title = {Serum metabolomics identifies ganglioside dysregulation and pyruvate dehydrogenase complex-related metabolic disturbances in pediatric drug-resistant epilepsy.},
  author = {Abu-Rish EY and  AlMalki RH and  Masri A and  Dahabiyeh LA and  Alnajjar R and  Darwish RM and  Abdel Rahman AM.},
  year = {2026},
  journal = {Front Pediatr},
  doi = {10.3389/fped.2026.1952153},
  url = {https://doi.org/10.3389/fped.2026.1952153}
}

RIS

TY  - JOUR
TI  - Serum metabolomics identifies ganglioside dysregulation and pyruvate dehydrogenase complex-related metabolic disturbances in pediatric drug-resistant epilepsy.
AU  - Abu-Rish EY
AU  -  AlMalki RH
AU  -  Masri A
AU  -  Dahabiyeh LA
AU  -  Alnajjar R
AU  -  Darwish RM
AU  -  Abdel Rahman AM.
PY  - 2026
JO  - Front Pediatr
DO  - 10.3389/fped.2026.1952153
UR  - https://doi.org/10.3389/fped.2026.1952153
ER  - 

APA

EY, A., RH, A., A, M., LA, D., R, A., RM, D., & AM., A. R. (2026). Serum metabolomics identifies ganglioside dysregulation and pyruvate dehydrogenase complex-related metabolic disturbances in pediatric drug-resistant epilepsy.. Front Pediatr. https://doi.org/10.3389/fped.2026.1952153

Source records